Kaneka Corporation

4118.T
Specialty Chemicals
2026/08/21 Updated
Market Cap: $2.3B (¥368.2B)
Stock Price: $38.56 (¥6,131)
Exchange Rate: 1 USD = ¥158.98

FY2027 Q1 Earnings Presentation

Revenue was 223.0 billion yen, up 12.3% year over year, with operating income of 14.9 billion yen, up 83.1% YoY. Segments Materials/SU Quality of Life, Health Care, and Nutrition performed well. Going forward, growth strategies for each segment are expected to continue.

Importance:
Page Updated: August 13, 2026
IR Disclosure Date: August 13, 2026

Key Figures

  • Revenue: 2,230 (YoY 12.3%)
  • Operating Income: 149 (YoY 83.1%)
  • Ordinary Income: 138 (YoY 127.7%)

AI要約

Business Performance Overview

The Q1 FY2027 results show revenue increasing year over year, with substantial increases in operating and ordinary income. Segments Material SU, Quality of Life SU, Health Care SU, and Nutrition SU showed solid performance, contributing to overall revenue and profit growth. New initiatives such as price adjustments and strengthening of stable supply contributed positively.

Outlook and Strategy

From the second quarter onward, we will continue stable supply and pricing strategies across all segments. In particular, we will push expansion in Health Care and Nutrition, and seek to expand sales in overseas markets. We will continue measures aimed at responding to demand recovery in EV/materials-related areas in global markets.

Revenue Trend

Operating Income Trend

Revenue by Segment

Profit Margin Analysis

Actual vs Forecast

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Kaneka Corporation

Company overview · Stock price · Financial data · All IR

View company page →